1. Home
  2. ASRV vs NXTC Comparison

ASRV vs NXTC Comparison

Compare ASRV & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AmeriServ Financial Inc.

ASRV

AmeriServ Financial Inc.

N/A

Current Price

$3.15

Market Cap

54.2M

Sector

Finance

ML Signal

N/A

Logo NextCure Inc.

NXTC

NextCure Inc.

N/A

Current Price

$13.98

Market Cap

46.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASRV
NXTC
Founded
1983
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.2M
46.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ASRV
NXTC
Price
$3.15
$13.98
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$23.00
AVG Volume (30 Days)
15.9K
38.8K
Earning Date
01-20-2026
11-05-2025
Dividend Yield
3.80%
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
$53,488,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.54
N/A
Revenue Growth
17.45
N/A
52 Week Low
$2.03
$2.69
52 Week High
$3.42
$15.74

Technical Indicators

Market Signals
Indicator
ASRV
NXTC
Relative Strength Index (RSI) 57.10 60.28
Support Level $3.12 $12.99
Resistance Level $3.34 $14.65
Average True Range (ATR) 0.12 1.00
MACD 0.01 0.08
Stochastic Oscillator 74.26 78.55

Price Performance

Historical Comparison
ASRV
NXTC

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: